Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): Hyperlipidemia

Dyslipidemia is a significant contributor to cardiovascular morbidity and mortality worldwide. This chapter explores the clinical, economic, and humanistic impact of pharmacist-provided care in managing dyslipidemia across diverse healthcare settings. Pharmacists play a critical role in improving lipid profiles, medication adherence, patient education, and cardiovascular risk reduction through collaborative and patient-centered interventions. Evidence from clinical studies reveals that pharmacist involvement leads to significant improvements in LDL-C levels, total cholesterol, and triglycerides. Pharmacist-led services, including lipid management clinics and telepharmacy, have demonstrated cost-effectiveness, reduced healthcare utilization, and improved patient satisfaction. Despite these positive outcomes, challenges remain, such as inconsistent reimbursement policies, variable integration in multidisciplinary teams, and limited studies on long-term outcomes and quality of life. This chapter underscores the need for broader implementation of pharmacist services, 46 standardized outcome reporting, and further research into sustainable models of care and societal cost-benefit analyses.